Metvix Photodynamic Therapy
Metvix photodynamic therapy for the treatment of Superficial skin cancers.
Metvix also known as Methyl Aminolevulinate,is a topical cream is indicated for the management of Actinic Keratosis and Primary superficial Basal cell Cancer.
Metvix,when exposed to a specific wavelength of light called Light emitting diode, developed specifically for use with metvix, causes destruction of abnormal cells while sparing the healthy surrounding tissue.
Healing occurs,with cosmetic outcomes assessed as superior to surgery at 3,6 and 12 month follow up.
It combines,clinically proven long term therapeutic efficacy and excellent cosmetic results to treat superficial skin cancers.
Metvix offers important advantages in that it is a noninvasive procedure with minimal downtime, minimal risk of scarring and limited impact on social activities compared to those treated with standard excision surgery.
COME FACE TO FACE WITH A BREAKTHROUGH THERAPY.